Are parkin patients particularly suited for deep-brain stimulation?

Movement Disorders

Volumn 23, Issue 5, 2008, Pages 740-743

  Lohmann, Ebba ^a,b,c   Welter, Marie Laure ^c   Fraix, Valérie ^d   Krack, Paul ^d   Lesage, Suzanne ^a,b,c   Laine, Sophie ^a,b,c   Tanguy, Marie Laure ^c   Houeto, Jean Luc ^e   Mesnage, Valérie ^c   Pollak, Pierre ^a,d   Durr, Alexandra ^a,b,c   Agid, Yves ^a,b,c   Brice, Alexis ^a,b,c   Bonnet, A M ^f   Borg, M ^f   Broussolle, E ^f   Damier, Ph ^f   Destee A ^f   Durr A ^f   Durif, F ^f   Houeto, J L ^f   Lohmann, E ^f   Martinez, M ^f   Penet, C ^f   Pollak, P ^f   Rascol, O ^f   Tison, F ^f   Tranchant, C ^f   Verin M ^f   Viallet, F ^f   Vidailhet, M ^f   Warter, J M ^f   more..

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e POITIERS UNIVERSITY HOSPITAL   (France)

^f CHU Grenoble ^*

Author keywords

Deep brain stimulation; Early onset Parkinsonism; Parkin; Parkinson disease

Indexed keywords

LEVODOPA; PARKIN; ANTIPARKINSON AGENT; UBIQUITIN PROTEIN LIGASE;

ARTICLE; BRAIN DEPTH STIMULATION; DOSE RESPONSE; DRUG MEGADOSE; DYSKINESIA; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MUTATIONAL ANALYSIS; NEUROSURGERY; PARKINSON DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE DRUG DOSE; THERAPY EFFECT; ADULT; AGED; FOLLOW UP; GENETIC SCREENING; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PARKINSONISM; TREATMENT OUTCOME;

ADULT; AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DNA MUTATIONAL ANALYSIS; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; GENETIC SCREENING; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS; TREATMENT OUTCOME; UBIQUITIN-PROTEIN LIGASES;

EID: 44449119363     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21903     Document Type: Article

References (15)

1. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile Parkinsonism. Nature 1998; 392:605-608.
2. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003; 54:176-185.
3. Khan NL, Graham E, Ciritchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-1292.
4. Kann M, Jacobs H, Mohrmann K, et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonim. Ann Neurol 2002;51:621-625.
5. Kubo S, Hattori N, Mizuno Y. Recessive Parkinson's disease. Mov Disord 2006;21:885-893.
6. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21:290-304.
7. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset Parkinsonism. Brain 2003;126:1271-1278.
8. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92:615-625.
9. Lesage S, Magali P, Lohmann E, et al. Deletion of the parkin and PACRG gene promoter in early-onset Parkinsonism. Hum Mutat 2007;28:27-32.
10. Piccini P, Pavese N, Hagell P, et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005;128:2977-2986.
11. Pillon B, Boller F, Levy R, Dubois B. Cognitive deficits and dementia in Parkinson's disease. In: Boller F, Grafman J, editors. Handbook of neuropsychology, Vol. 6. Amsterdam: Elsevier; 2001.
12. Hilker R, Klein C, Hedrich K, et al. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 2002;323:50-54.
13. Sun M, Latourelle J, Wooten F, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease. Arch Neurol 2006;63:826-832.
14. Romito LM, Contarino MF, Ghezzi D, et al. High frequency stimulation of the subthalamic nucleus is efficacious in parkin disease. J Neurol 2005;252:208-211.
15. Capecci M, Passamonti L, Annesi F, et al. Chronic bilateral subthalamic deep brain stimulation in a patient with homozygous deletion in the parkin gene. Mov Disord 2004;19:12.